Based on an OHE lunchtime seminar by Professor Henry Grabowski, this seminar briefing explores the lessons learned from Europe’s experience with biosimilars, and provides an analysis of how the US market may evolve.
Discussed yesterday at an OHE Lunchtime Seminar is a new journal article that explores the possible connection between hospital competition and outcomes for non-emergency hip replacement surgery in England.
Jon Sussex was a keynote speaker at the Capita conference on competition in health care held in June, where the audience was primarily from the NHS. Jon’s presentation summarised the state of provider competition in the NHS to date as well as national and international evidence about the impact of competition on quality.
OHE’s Jon Sussex has studied and written extensively on competition in the NHS. He was a member of the OHE Commission on Competition in the NHS and rapporteur of its 2012 report. We asked him to comment on the latest NHS competition regulations. Last week the UK’s coalition government published a revised draft of regulations to govern competition among providers of health care funded by the NHS in England.
OHE’s research and consulting captures a range of key issues that affect how health care systems are organised and how decisions are made within them. For example, how far to incorporate competition in the provision of NHS-funded health care in England was the focus of the OHE Commission on Competition, which published its report in January 2012.
The role of competition in the NHS is again in the news. Sir David Nicholson, Chief Executive of both the NHS in England and the NHS Commissioning Board, voiced his concern at a Royal College of General Practitioners conference last week, saying: “It [competition] is very effective when it is used as a rifle shot to deal with specific issues rather than a carpet bombing”. We agree.